Marksans Pharma Limited — Updates, 16-06-2026: General Updates
16-06-2026 | 02:44 pm
16-06-2026 | 02:44 pm
Marksans Pharma completed the acquisition of 100% share capital of Netherlands-based QliniQ B.V. This strategic move strengthens its European operational footprint, a key business development.
No comments yet. Be the first to comment!
